Skip to content

Study of Turmeric gel for faster healing of post delivery incision

A Clinical Study on the Evaluation of Haridra (Curcuma longa Linn.) Loaded Niosomal Gel for Episiotomy Wound Healing with Special Reference to Vrana Ropana. - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/11/097693
Enrollment
30
Registered
2025-11-19
Start date
Unknown
Completion date
Unknown
Last updated
2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O860- Infection of obstetric surgical wound

Interventions

None listed

Sponsors

Kunwar Shekhar Vijendra Ayurved Medical College and Research Centre
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: .women age between 18 to 35 who have undergoes normal vaginal delivery with mediolateral episiotomy .primiparous women .Healthy term pregnancy .REEDA score equivalent or less than 4 .who can attain hospital for a regular follow up .patients who give written informed consent for the clinical trial .singleton vaginal delivery

Exclusion criteria

Exclusion criteria: .women of age less than 18 years and more than 35 years .episiotomy wound infection already present at day 1 .women with intrumental deliveries (foreceps or vaccum assisted) .multiparous women .known case of diabetes mellitus,hypertension , or immunocompromised status .known allergy ,hypersensitivity .post partum complications

Design outcomes

Primary

MeasureTime frame
to assess the rate and quality of wound healing using Haridra loaded niosomal gel .to evaluate changes in redness,oedema ,ecchymosis, discharge ,approximation score, and pain (VAS scale) during the healing processTimepoint: Day 1(baseline) ,day 7,day 15 and with additional observation at day 21 and day 30 to evaluate sustained healing and late occuring effect

Secondary

MeasureTime frame
to assess the antimicrobial effect of Haridra loaded niosomal gelTimepoint: Day 1 (baseline), day 7, day 15 and with additional observation at day 21, and day 30 to evaluate sustained healing and late occuring effect

Countries

India

Contacts

Public ContactDr R Jayalekshmi

Kunwar shekhar vijendra ayurved medical college and research centre, Shobhit university ,Gangoh

dr.lekshmy83@gmail.com8838460272

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026